Trade Summary

4 days ago, Lange Louis G, serving as Dir at Newamsterdam Pharma Co N.V. (NAMS), sold 44,619 shares at $30.42 per share, for a total transaction value of $1,357,230.00. Following this transaction, Lange Louis G now holds 10,360 shares of NAMS.

This sale represents a 81.00% decrease in Lange Louis G's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 11, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 1 day after the trade was made.

Newamsterdam Pharma Co N.V. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.